Finding the best prices at pharmacies near you...

Blog - FDA

Azedra: First treatment for rare adrenal tumors approved by FDA

The US Food and Drug Administration (FDA) has approved Azedra (iobenguane I 131), the first drug approved for treatment of rare unresectable adrenal gland tumors that spread beyond the original tumor site and need treating with a systemic anti-cancer therapy.  Adrenal glands, situated above...

Read More

Biosimilar for cancer drug Neupogen approved by FDA

Patients with neutropenia may have improved access to treatment following the US Food and Drug Administration’s (FDA’s) approval of Nivestym (filgrastim-aafi), a biosimilar for Amgen biologic Neupogen (filgrastim).  The FDA’s approval of the biosimilar was based on a review...

Read More

FDA approves first plant-derived cannabinoid (CBD) drug

Epidiolex (cannabidiol) is the first medication based on a purified drug substance, cannabidiol (CBD), derived from marijuana to gain approval from the US Food and Drug Administration (FDA). The drug is indicated for patients aged two years and older with Lennox-Gastaut syndrome or Dravet...

Read More

Tagrisso approved as first-line treatment for metastatic NSCLC

The US Food and Drug Administration (FDA) has approved the protein kinase inhibitor Tagrisso (osimertinib) as a first-line treatment option for certain patients with metastatic non-small cell lung carcinoma (NSCLC). Earlier this month, AstraZeneca presented new data from a Phase III FLAURA trial...

Read More

FDA okays first drug therapy for rare inherited form of rickets

The US Food and Drug Administration (FDA) has approved Crysvita (burosumab) as a treatment for a rare form of inherited rickets. It is the first drug therapy approved as a treatment for x-linked hypophosphatemia (XLH) with evidence of bone disease in children over one year of age and adolescents...

Read More